Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2013-11-10 Proxy Solicitation & In…
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
关于召开2013年第二次临时股东大会的再次通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about the convening of the 2013 second extraordinary general meeting of shareholders for the company 中源协和干细胞生物工程股份公司. It includes information about the meeting date, voting procedures (including online voting), agenda items to be discussed, registration methods, and other logistical details. There is no financial data, earnings information, or audit results presented. The document is not a report itself but a formal announcement and notification about the shareholder meeting and voting process. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is a notice about the meeting and voting procedures rather than the solicitation of proxies or the actual voting results, it aligns best with Proxy Solicitation & Information Statement (PSI). The document length is about 4768 characters, which is substantial and contains detailed procedural information, supporting this classification.
2013-11-10 Chinese
2013年第二次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as materials for the 2013 second extraordinary shareholders meeting of Zhongyuan Xiehe Stem Cell Bioengineering Co., Ltd. It includes the meeting agenda, voting procedures, and detailed proposals for shareholder approval, such as extending the validity of a previous stock issuance resolution, extending authorization for the board to handle issuance matters, and changing the company's 2013 audit firm. The document is a meeting material packet, not a report itself, and it is not a voting result announcement but rather the preparatory materials for the meeting. This fits the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or Extraordinary General Meeting. The document length is under 5,000 characters, but it contains substantive meeting materials, not just an announcement of a report publication. Therefore, the correct classification is AGM Information (AGM-R).
2013-11-06 Chinese
第七届董事会第三十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of the company. It includes details about the meeting date, voting results, and decisions made, such as extending the validity of a stock issuance resolution, changing the audit firm, and scheduling a shareholders' meeting. The content focuses on board decisions and management actions rather than presenting financial statements or detailed financial performance. It is not a full annual or quarterly report, nor is it an earnings release or audit report by itself. The document is clearly a Board/Management Information announcement about board meeting resolutions and related corporate governance matters.
2013-10-30 Chinese
关于召开2013年第二次临时股东大会的通知
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed notice about the convening of the 2013 second extraordinary general meeting of shareholders for the company 中源协和干细胞生物工程股份公司. It includes information about the meeting date, voting procedures (including online voting), agenda items to be discussed and voted on, registration methods, and other logistical details. It also contains attachments such as a proxy authorization form and instructions for online voting. There are no financial statements, audit results, or earnings data presented. The document is not a report itself but a formal announcement and notice for a shareholders meeting, including voting instructions and agenda. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or possibly Proxy Solicitation & Information Statement (PSI). However, since it is a notice of the meeting and voting procedures rather than solicitation materials or proxy statements, the best fit is Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 4617 characters, which is sufficient for a detailed notice but does not contain actual voting results, only the notice and instructions. Given the content, the classification is DVA with high confidence.
2013-10-30 Chinese
2013年第三季度报告
Interim / Quarterly Report Classification · 95% confidence The document is titled as the "2013 Third Quarter Report" of the company 中源协和干细胞生物工程股份公司 (Zhongyuan Xiehe Stem Cell Bioengineering Co., Ltd.). It contains detailed financial data including consolidated balance sheets, profit and loss statements, cash flow statements, and notes on significant changes in financial items. The report covers the period ending September 30, 2013, which is a quarterly period. The financial statements are unaudited, which is typical for interim or quarterly reports. The document includes management's discussion of financial results, shareholder information, and other disclosures typical of an interim or quarterly report. It is not an annual report (10-K), nor is it an earnings release (which would be shorter and less detailed). It is not a call transcript, audit report, or any other category. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). The document length (15,000 characters) and content confirm it is the full report, not just an announcement or certification, so it is not RPA or RNS. 9M 2013
2013-10-30 Chinese
关于控股股东部分股权解除质押的公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement regarding the release of pledged shares by a controlling shareholder. It details the number of shares released from pledge and the remaining pledged shares. There is no financial report, no management discussion, no earnings data, and no mention of a meeting or voting results. The content fits the category of a capital structure update related to share pledges. Therefore, it is best classified as a Capital/Financing Update (CAP). The document length is short and focused on financing activity, not a report publication or regulatory filing. Confidence is high due to clear content and context.
2013-10-23 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.